I partially disagree, not from the investment point of view, but probably from the scientific point of view (I am not a scientist by the way) Many biotech companies operate in the same way until they come up with a big and innovative product that change the world. I think (hope) ACTC will do that sooner rather than later, but I can wait. The only thing that will cripple everyone out is bankruptcy, and I hope that doesn't happen.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.